| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | VP Reg. Affairs & Quality | Stock Options (Right to Buy) | 50,000 | $76,000 | $1.52 | 07 Jun 2023 | Direct |
| Bellerophon Therapeutics, Inc. | VP Reg. Affairs & Quality | Common Stock | 1,723 | $179 | $0.1038 | 18 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | VP Reg. Affairs & Quality | 09 Jun 2023, 16:10 |
| BLPH | Bellerophon Therapeutics, Inc. | 18 May 2023 | 5 | -$84,929 | 4 | VP Reg. Affairs & Quality | 22 May 2023, 18:51 |
| BLPH | Bellerophon Therapeutics, Inc. | 30 Mar 2023 | 0 | $0 | 3 | VP Reg. Affairs & Quality | 03 Apr 2023, 17:46 |